Omega Therapeutics Inc (OMGA)
1.12
+0.06
(+6.16%)
USD |
NASDAQ |
Nov 05, 14:40
Omega Therapeutics Total Liabilities (Quarterly): 141.96M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 141.96M |
| March 31, 2024 | 142.33M |
| December 31, 2023 | 146.35M |
| September 30, 2023 | 141.76M |
| June 30, 2023 | 133.10M |
| March 31, 2023 | 33.32M |
| December 31, 2022 | 40.03M |
| September 30, 2022 | 36.41M |
| Date | Value |
|---|---|
| June 30, 2022 | 35.66M |
| March 31, 2022 | 35.95M |
| December 31, 2021 | 32.70M |
| September 30, 2021 | 22.93M |
| June 30, 2021 | 222.53M |
| March 31, 2021 | 221.95M |
| December 31, 2020 | 92.71M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
22.93M
Minimum
Sep 2021
222.53M
Maximum
Jun 2021
98.65M
Average
92.71M
Median
Dec 2020
Total Liabilities (Quarterly) Benchmarks
| Moderna Inc | 3.968B |
| NovaBay Pharmaceuticals Inc | 4.542M |
| Palatin Technologies Inc | 10.85M |
| iBio Inc | 7.41M |
| Theriva Biologics Inc | 14.74M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 168.22M |
| Shareholders Equity (Quarterly) | 26.26M |
| Debt to Equity Ratio | 0.6439 |
| Current Ratio | 2.195 |
| Net Debt Paydown Yield | 0.53% |